Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Antimetabolites (Phase 2)
Antineoplastic Agents (Phase 2)
Biliary Tract Neoplasms (Phase 2)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 4)
Carcinoma, Non-Small-Cell Lung (Phase 1)
Colorectal Neoplasms (Phase 3)
Digestive System Neoplasms (Phase 2)
Drugs, Investigational (Phase 2)
Esophageal Neoplasms (Phase 2)
Fluorouracil (Phase 2)
Healthy Volunteers (Phase 1)
Intestinal Neoplasms (Phase 2)
Leukemia, Myeloid, Acute (Phase 1)
Liver Neoplasms (Phase 2)
Nasopharyngeal Carcinoma (Phase 1)
Neoplasms (Phase 2)
Oxaliplatin (Phase 2)
Pancreatic Neoplasms (Phase 2)
Stomach Neoplasms (Phase 1/Phase 2)
Thyroid Neoplasms (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue